SCHEMBL7072437

SCHEMBL7072437

CCCOc1ccc(C(c2cc(C=O)ccc2O)c2cc(C=O)ccc2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
PTGS2 P35354 2/20 0.45
PTGS1 P23219 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ERN1 O75460 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.41
LTA4H P09960 1/20 0.40
TRIM24 O15164 1/20 0.39
ALDH5A1 P51649 1/20 0.39
ABAT P80404 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074332 0.82 ALDH1A1 (0.51) ALDH1A1PTGS2PTGS1MEN1KMT2A
SCHEMBL7681882 0.80 ALDH1A1 (0.46) ALDH1A1PTGS2HPGDTRIM24ALDH5A1
SCHEMBL7071774 0.80 ALDH1A1 (0.39) ALDH1A1PTGS2PTGS1MEN1KMT2A
SCHEMBL7073812 0.77 ALDH5A1 (0.50) ALDH1A1PTGS2KMT2AHPGDMAPT
SCHEMBL10145024 0.76 ALDH1A1 (0.42) ALDH1A1PTGS2MEN1KMT2AHPGD
SCHEMBL541949 0.75 ALDH1A1 (0.68) ALDH1A1PTGS2PTGS1MEN1KMT2A
SCHEMBL14134159 0.75 ALDH1A1 (0.68) ALDH1A1PTGS2PTGS1MEN1KMT2A
SCHEMBL10145052 0.75 ALDH1A1 (0.41) ALDH1A1PTGS2HPGDLMNASMN1; SMN2
SCHEMBL7676281 0.75 KDM4E (0.47) ALDH1A1PTGS2PTGS1MEN1KMT2A
SCHEMBL7074379 0.74 KDM4E (0.50) ALDH1A1PTGS2HPGDTRIM24ALDH5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases NITZ THEODORE J (US) 2003-05-15 US disclosed
US-6495580-B1 A BENZYLIDENE DERIVATIVE CONTAINING HETEROCYCLIC RING IS USEFUL AS PNEUMOVIRUS INHIBITOR VIROPHARMA INCORPORATED 2002-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092685-A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases TTPA, HAVCR2, PML ALDH1A1 3369/4885PTGS2 935/4885PTGS1 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.